Webinar | Is your natural food dye compliant, shelf-stable, and ready to scale?
24th July | 12 PM ET: Register Now

Mirador Therapeutics

Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases.
2024
11-50
San Diego, California, United States
  • Drug Discovery and Development
  • Oncology (Cancer)
  • Pathology & Diagnostics
  • Personalized Medicine Technologies

Investment Funding

Last Funding Stage

Venture - Series Unknown

Total Funding Amount

480.M

Last Funding Amount

80.M

Last Funding Date

03-04-2024

Lead Investors

Blue Owl, Sanofi, OrbiMed, ARCH Venture Partners, RTW Investments

People

Founders

Something missing or incorrect on this page? Help us enrich this information